GPA33 and colorectal carcinoma: Treatment of subcutaneous CRC SW1222 xenografts in mice with either anti-GPA33 or anti-HER2 225Ac-DOTA-PRIT resulted in CRs and histological cures in a subset of the long-term survivors without apparent toxicity to healthy organs.